VANCOUVER, Nov. 8, 2012 /CNW/ - Vertical Designs Ltd. of Vancouver, B.C.
is moving rapidly into the biotech, pharmaceutical, and nutraceutical
arenas. The company has recently signed a letter of intent with Cromogen Biotechnology, a licensed research and development firm with offices in Central and
South America. The union will spark cooperative research toward the
augmentation of phytocannabinoids, (also called "natural cannabinoids")
through environmental changes and breeding.
Cromogen CEO, Michael Brubeck reports,"Cromogen sees great opportunity in
accelerating research into cannabis plant physiology with Vertical
Designs. With Stage 3 clinical trials beginning in Q2 2013, this will
give our company greater efficiency in manufacturing isolated
non-psychoactive molecules for use in our combination drug therapy,
targeted for chemotherapy-induced nausea."
"Cromogen offers a wealth of experience in greenhouse-based technology.
As this team merges into the vertical farming arena, we see tremendous
potential for even further advancement," says Vertical Designs CEO,
Nick Brusatore. "This progressive alliance will serve our vision to
revolutionize agricultural and pharmaceutical practices on a global
Vertical Designs has plans to spin off a wholly owned subsidiary company
that will hold exclusive master licensing and rights of advanced
designs in the biotech, pharmaceutical, and nutraceutical arenas. The
firm will be seeking a capital partner in the near future.
About Vertical Designs Ltd.
Vertical Designs Ltd. designs and manufactures cutting-edge vertical
farming technology. The company is helmed by Nick Brusatore - an
innovative eco-entrepreneur, natural capitalist, mechanical designer,
About Cromogen Biotech.
Cromogen is a research and development firm for cannabinoid-class
molecules in Latin America, with approvals for clinical trials from the
Department of Health in multiple countries. With a portfolio of
proprietary administration methods and unparalleled quality control
systems, Cromogen is defining the market for cannabinoid-class
pharmaceuticals and is poised to become the region's
sole cannabinoid pharmaceutical company.
SOURCE: Vertical Designs Ltd.
For further information:
Nick Brusatore, Chief Executive Officer, Vertical Designs Ltd.
PHONE: (604) 356-0411